Back to companies

Horizon Therapeutics Plc: Patents

View up-to-date information on Horizon Therapeutics Plc patents, including inventor and filing insights.

Patent Trends

Publication Identifier Document Type Title Classification-CPC Publication Date
JP7068231B2 Grant CD40L特異的Tn3由来足場およびその使用方法 A61K38/39; A61K38/39; A61K38/39; A61P1/04; A61P1/04; A61P1/16; A61P1/16; A61P11/00; A61P13/12; A61P15/00; A61P17/00; A61P17/06; A61P17/06; A61P17/14; A61P17/14; A61P19/00; A61P19/02; A61P21/02; A61P21/04; A61P25/00; A61P27/02; A61P27/06; A61P29/00; A61P3/06; A61P3/10; A61P31/04; A61P35/00; A61P37/02; A61P37/06; A61P37/08; A61P5/14; A61P5/38; A61P7/00; A61P7/06; A61P9/00; A61P9/10; C07K14/78; C07K14/78; C07K14/78; C07K16/2875; C07K16/2875; C07K16/2875; C07K2318/20; C07K2318/20; C07K2318/20; C07K2319/21; C07K2319/21; C07K2319/21; C07K2319/30; C07K2319/30; C07K2319/30; C07K2319/31; C07K2319/31; C07K2319/31 May 16, 2022
US20220144940A1 Application ILT7 BINDING MOLECULES AND METHODS OF USING THE SAME A61K2039/505; A61P37/00; C07K16/26; G01N33/564 May 12, 2022
JP7064666B2 Grant FcγRIIAに特異的な結合分子及びその使用 A61K2039/505; A61P1/16; A61P11/00; A61P13/12; A61P17/00; A61P19/02; A61P19/04; A61P21/00; A61P29/00; A61P3/10; A61P31/04; A61P37/00; A61P37/02; A61P37/06; A61P39/02; A61P43/00; A61P7/00; A61P7/04; A61P7/06; A61P9/00; A61P9/10; C07K16/283; C07K2317/24; C07K2317/33; C07K2317/56; C07K2317/565; C07K2317/76; C07K2317/77; C07K2317/92 May 11, 2022
WO2022094334A1 Application USE OF AN ANTI-CD19 ANTIBODY TO TREAT AUTOIMMUNE DISEASE May 05, 2022
US11306145B2 Grant Binding molecules specific for Fc?RIIA and uses thereof A61P7/00; C07K16/283; C07K2317/24; C07K2317/33; C07K2317/565; C07K2317/76; C07K2317/77; C07K2317/92 April 19, 2022
Discover Company Analytics for more exclusive patent trend analysis Discover Company Analytics for more exclusive patent trend analysis Get Started

Top Inventors by Filings (Count by publication)

Name Count
Identify the top inventors associated with your target company when you subscribe Identify the top inventors associated with your target company when you subscribe Learn More
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer